
Enfermedad de Stargardt
A menudo diagnosticada en la niñez o adolescencia, la enfermedad de Stargardt es una forma hereditaria de degeneración macular que causa pérdida de visión central. La condición a veces es denominada degeneración macular juvenil o de arranque temprano.
Podcasts
-
Eye on the Cure Podcast | Episode 80: Aniz Girach, MD
Aniz Girach talks about the company’s emerging protein-splicing therapy for Stargardt disease which has received clearance from the FDA to move into a clinical trial.
-
Eye on the Cure Podcast | Episode 77: Dr. Bob Bell
Dr. Bell, the CSO of Ascidian Therapeutics, talks about STELLAR, the company’s Phase ½ clinical trial for its emerging RNA-rewriting therapy for Stargardt disease (ABCA4 mutations).
-
Eye on the Cure Podcast | Episode 71: Dr. Leonide Saad
Dr. Saad discusses an emerging therapy for Stargardt disease that has performed well in clinical trials.